BioSpace News Archive

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the appointment of three new members to the company’s board of directors, effective immediately.

PDS Biotech ramps up third infectious disease vaccine program, PDS0202 for influenza, following PDS0201 for tuberculosis and PDS0203 for COVID-19

Castlight Health, Inc. (NYSE:CSLT), a leading health benefits platform provider, will release its second quarter 2020 financial results on Tuesday, July 28, 2020, after the market close

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that Brian H. Santich, PhD, from Memorial Sloan Kettering (“MSK”) will present an update on the Company’s SADA technology platform at the Society of Nuclear Medicine and Molecular Imaging (“SNMMI”)

Waystar, a leading provider of revenue cycle technology for the healthcare industry, today announced the appointment of Ursula Burns, retired Chair and CEO of VEON Ltd. and Xerox Corporation, to its board of directors.

Celdara Medical (“Celdara”) today announced the launch of its Pandemic Security Initiative, harnessing the resources needed to prepare the nation for future infectious disease pandemics.

Aatru Medical, LLC (“Aatru”) is pleased to announce its recent submission to the FDA of a traditional 510(k) premarket notification application for the company’s first product, NPSIMS™ - Negative Pressure Surgical Incision Management System

FHI Clinical Inc. contracted by Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc., to provide operational support for NIAID-funded study DURHAM, N.C.--( BUSINESS WIRE )-- FHI Clinical Inc. announced that it has a subcontract with the Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc., to provide clinical operations services for the Adaptiv

Cold plasma, additionally called non-warm plasma or non-balance plasma, is a sort of plasma—ordinarily known as the fourth condition of issue—which has gas particles show at direct temperature and electrons at moderately high temperatures.

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced the Company will participate in the following upcoming investor conferences